Inventor · disambiguated record
Gal Markel
Also filed as: MARKEL GAL
32 granted patents·18 pending applications·107 citations·filing 2005–2024
96Inventor score
Files withMARKEL GAL35TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD6FAMEWAVE LTD44C BIOMED LTD3CCAM BIOTHERAPEUTICS LTD2
Top patents by PatentIndex Score
50 records- 0194US2024424054A1Ceacam based antibacterial agentsMARKEL GAL·Filed 2024·Application pending·0 cites
- 0293US10105097B2Wearable items providing physiological, environmental and situational parameter monitoringMARKEL GAL·Filed 2016·Granted Oct 23, 2018·6 cites·13 claims
- 0393US8298544B2CEACAM based antibacterial agentsMARKEL GAL·Filed 2007·Granted Oct 30, 2012·8 cites·2 claims
- 0492US10765719B2CEACAM based antibacterial agentsMARKEL GAL·Filed 2018·Granted Sep 8, 2020·2 cites·3 claims
- 0592US9889175B2CEACAM based antibacterial agentsMARKEL GAL·Filed 2016·Granted Feb 13, 2018·4 cites·1 claims
- 0692US8598322B2Anti CEACAM1 antibodies and methods of using sameMARKEL GAL·Filed 2010·Granted Dec 3, 2013·21 cites·18 claims
- 0791US9526452B2Wearable items providing physiological, environmental and situational parameter monitoringMARKEL GAL·Filed 2015·Granted Dec 27, 2016·5 cites·50 claims
- 0890US11433113B2CEACAM based antibacterial agentsMARKEL GAL·Filed 2020·Granted Sep 6, 2022·1 cites·3 claims
- 0990US9694046B2CEACAM based antibacterial agentsMARKEL GAL·Filed 2012·Granted Jul 4, 2017·4 cites·2 claims
- 1089US12076365B2CEACAM based antibacterial agentsMARKEL GAL·Filed 2022·Granted Sep 3, 2024·0 cites·3 claims
- 1188US11866509B2Humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2020·Granted Jan 9, 2024·2 cites·18 claims
- 1288US11793894B2Modulation of immunity and CEACAM1 activityMARKEL GAL·Filed 2019·Granted Oct 24, 2023·1 cites·2 claims
- 1387US9131892B2Wearable items providing physiological, environmental and situational parameter monitoringMARKEL GAL·Filed 2010·Granted Sep 15, 2015·21 cites·51 claims
- 1486US2025199000A1Ceacam1 based point-of-care cancer diagnosticMARKEL GAL·Filed 2024·Application pending·0 cites
- 1585US9238838B2Microrna patterns for the diagnosis, prognosis and treatment of melanomaTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2014·Granted Jan 19, 2016·3 cites·11 claims
- 1683US8735157B2CEACAM1 mediated protective immunityMARKEL GAL·Filed 2006·Granted May 27, 2014·3 cites·3 claims
- 1782US9771431B2Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2012·Granted Sep 26, 2017·5 cites·19 claims
- 1881US10993490B2Wearable items providing physiological, environmental and situational parameter monitoringMARKEL GAL·Filed 2018·Granted May 4, 2021·2 cites·20 claims
- 1980US9795696B2CEACAM1 based cancer therapy and diagnosisMARKEL GAL·Filed 2006·Granted Oct 24, 2017·2 cites·2 claims
- 2079US2022001042A1Ceacam1 mediated protective immunityMARKEL GAL·Filed 2021·Application pending·0 cites
- 2178US10550196B2Humanized antibodies against CEACAM1CCAM BIOTHERAPEUTICS LTD·Filed 2015·Granted Feb 4, 2020·3 cites·16 claims
- 2278US2022001041A1Ceacam1 based cancer therapy and diagnosisMARKEL GAL·Filed 2021·Application pending·0 cites
- 2377US7546839B2Colored smoke module for cigaretteMARKEL GAL·Filed 2005·Granted Jun 16, 2009·5 cites·12 claims
- 2476US9731036B2CEACAM1 mediated protective immunityMARKEL GAL·Filed 2014·Granted Aug 15, 2017·1 cites·1 claims
- 2576US9261507B2Anti CEACAM1 antibodies and methods of using sameTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2013·Granted Feb 16, 2016·2 cites·6 claims
- 2675US12016412B2Wearable items providing physiological, environmental and situational parameter monitoringMARKEL GAL·Filed 2021·Granted Jun 25, 2024·0 cites·20 claims
- 2772US12130287B2CEACAM1 based point-of-care cancer diagnosticMARKEL GAL·Filed 2020·Granted Oct 29, 2024·0 cites·1 claims
- 2872US8267095B2Colored smoke module for cigaretteMARKEL GAL·Filed 2008·Granted Sep 18, 2012·2 cites·12 claims
- 2969US10188760B2Modulation of immunity and CEACAM1 activityMARKEL GAL·Filed 2014·Granted Jan 29, 2019·0 cites·5 claims
- 3069US2022175248A1Mobile communication device and other devices with cardiovascular monitoring capabilityMARKEL GAL·Filed 2022·Application pending·0 cites
- 3167US11891453B2Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)FAMEWAVE LTD·Filed 2020·Granted Feb 6, 2024·0 cites·20 claims
- 3267US9451895B2Mobile communication device and other devices with cardiovascular monitoring capabilityMARKEL GAL·Filed 2006·Granted Sep 27, 2016·4 cites·39 claims
- 3367US2018185525A1Ceacam1 based cancer therapy and diagnosisMARKEL GAL·Filed 2017·Application pending·0 cites
- 3466US2018177902A1Ceacam1 mediated protective immunityMARKEL GAL·Filed 2017·Application pending·0 cites
- 3565US2024067742A1Enhanced anti-hvem antibodies and use thereof4C BIOMED LTD·Filed 2023·Application pending·0 cites
- 3664US8815248B2Modulation of immunity and CEACAM1 activityMARKEL GAL·Filed 2006·Granted Aug 26, 2014·0 cites·3 claims
- 3762US2023287512A1Marker for response to pd-1/pd-l1 immunotherapy4C BIOMED LTD·Filed 2023·Application pending·0 cites
- 3862US2024092934A1Assessment of ceacam1 expression on tumor infiltrating lymphocytesFAMEWAVE LTD·Filed 2023·Application pending·0 cites
- 3960US10663464B2CEACAM1 based point-of-care cancer diagnosticMARKEL GAL·Filed 2008·Granted May 26, 2020·0 cites·4 claims
- 4057US11427647B2Polynucleotides encoding humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2019·Granted Aug 30, 2022·0 cites·19 claims
- 4157US11298020B2Mobile communication device and other devices with cardiovascular monitoring capabilityMARKEL GAL·Filed 2016·Granted Apr 12, 2022·0 cites·17 claims
- 4257US2018016338A1Anti ceacam1 antibodies and methods of using sameTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2017·Application pending·0 cites
- 4357US2013032157A1Colored smoke module for cigaretteMARKEL GAL·Filed 2012·Application pending·0 cites
- 4454US8980549B2MicroRNA patterns for the diagnosis, prognosis and treatment of melanomaMARKEL GAL·Filed 2011·Granted Mar 17, 2015·0 cites·4 claims
- 4552US2016176966A1Anti ceacam1 antibodies and methods of using sameTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2016·Application pending·0 cites
- 4650US2022227879A1Anti-hvem antibodies and use thereof4C BIOMED LTD·Filed 2020·Application pending·0 cites
- 4749US2017355781A1Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)CCAM BIOTHERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 4845US2006225755A1Cigarette with colored smokeMARKEL GAL·Filed 2005·Application pending·0 cites
- 4941US2012122122A1Method of diagnosing cancerMARKEL GAL·Filed 2010·Application pending·0 cites
- 5040US2016376374A1Antibodies to ceacam1 and kinase inhibitors for treating braf-mutated cellsTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gal Markel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →